Macerich Jumps As Analysts Hike Targets After Q2 Beat

Macerich Company (The) stocks have been trading up by 3.87 percent amid upbeat sentiment around retail REIT recovery.

Weekly Update Aug 03 – Aug 07, 2026: On Friday, August 07, 2026 Macerich Company (The) stock [NYSE: MAC] is trending up by 3.87%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Real Estate industry expert:

Analyst sentiment – positive

Macerich (MAC) occupies a challenged but improving position among U.S. mall REITs. Revenue growth (5.46%/3yr, 6.07%/5yr) and strong gross margin (54.3%) contrast with negative net margin (~-18%) and weak ROE (-7.2%), underscoring heavy interest burden (coverage 1.7x) and high leverage (debt/equity 1.99, LT debt/capital 67%). Q2 operating cash flow of $66.9M versus capex of $283.1M drives negative free cash flow and reliance on external funding, capping equity value despite portfolio quality.

Technically, MAC is consolidating after a sharp pullback. The weekly sequence from 25.87 to a 23.42 low, then a bounce to 24.40, shows a short-term correction within a still-intact medium-term uptrend, consistent with recent target upgrades into the high $20s. Intraday 5‑minute action (tight ranges, lighter volume near 23.5–24) indicates profit-taking rather than distribution. The key actionable level is support at $23.25–23.50; maintaining above it favors a rebound toward $26.

More Breaking News

• Redwire (RDW) Jumps As Defense Orders And Space Growth Align
• TWLO Stock Jumps After Earnings Beat And Bullish Guidance
• VATE Stock Pops As INNOVATE Corp Boosts Dividend Firepower
• FLR Stock Pops As Fluor Refocuses And Lands New FEED Work

Recent Q2 results beat on revenue and adjusted FFO, with NOI up 3.8% and occupancy reaching 94–95.5%, outpacing many retail REIT peers and supporting dividend continuity ($0.17/qtr, ~2.9% yield). Street targets clustered at $25–28 (Mizuho, Piper, Evercore) validate a recovery narrative versus broader REIT benchmarks. With improving fundamentals but still-elevated leverage risk, the risk-reward is favorable but not without balance sheet constraints; fair value sits at $27–28 with support at $23.5 and resistance near $26.5 then $28.

Quick Financial Overview

Macerich Company (The) delivered a mixed but generally constructive quarter for traders. On the positive side, adjusted funds from operations of $0.35 beat the $0.33 consensus, and revenue of about $249.7M topped Street estimates around $240M. Net operating income grew 3.8% on the go-forward portfolio, and occupancy improved to 94.0% overall and 95.5% for key centers, signaling healthy leasing demand.

Under the hood, the picture is more nuanced. Standard FFO of $0.32 per share was flat year over year and a touch below the $0.34 consensus, while net income for the quarter was slightly negative. Key ratios show strong gross margin near 54.3% and very high EBITDA margin above 60%, but profit margins are negative and returns on equity and assets are below zero. Leverage is heavy, with total debt to equity near 2.0 and interest coverage at 1.7, which keeps balance sheet risk on the radar.

For MAC traders, the Street’s reaction matters. Mizuho raised its price target to $28 with an Outperform call, while Piper Sandler also moved its target up to $28 but stayed Neutral, and Evercore ISI nudged its target to $25 with an In Line stance. Those clustered targets above the mid‑$20s mark create a reference zone for upside expectations. At the same time, a regular $0.17 quarterly dividend (annualized $0.68, roughly a 2.9% yield) shows management’s confidence in cash flows, even as recent free cash flow ran negative due to heavy capital expenditure.

Conclusion

The trading setup in Macerich Company (The) right now is about balancing improving operations against a leveraged, still‑loss‑making capital structure. On the tape, the weekly data show a sharp drop from $25.87 to an intraday low around $23.42 before a rebound toward the $24.40 area, telling you the post‑earnings reaction came with volatility and dip‑buying interest. Intraday, the 5‑minute chart shows a clear intraday uptrend from the low $23.60s into a steady grind above $24.00, then a firm close near $24.40, which signals demand stepping in on weakness.

Fundamentally, MAC traders are looking at a REIT with revenue growing modestly, NOI and occupancy moving the right way, but FFO stuck in place and GAAP earnings still negative. The balance sheet is geared, and interest coverage is thin, so any macro shock or rate spike would matter. On the other hand, multiple price‑target hikes clustering in the mid‑to‑high $20s and a maintained dividend point to Street belief that the worst is behind the name.

For short‑term traders, the key is how price behaves between the recent low near $23.40 and resistance in the mid‑$25s zone aligned with those targets. A clean hold above the $24.00 area keeps momentum buyers in control; a break back through the recent lows would warn that the bullish read‑through from earnings is fading. As I tell traders in my room, “You do not trade the story, you trade the levels the story creates – when price rejects a level with volume, that’s your edge, not the headline itself.” And that edge has to be clear: as Tim Bohen, lead trainer with StocksToTrade says, “If you’re still guessing at the end of your analysis, it’s probably not a trade worth taking.”

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

• How to Read Stock Charts: A Guide for Beginners
• Trading Plan: 6 Steps to Create One
• How To Create a Stock Watchlist

Ready to build your watchlists? Check out these curated lists:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.